UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. フローボリューム曲線 flow volume loops
2. HIV感染患者における肺アスペルギルス症および侵襲性疾患の疫学および臨床症状 epidemiology and clinical manifestations of pulmonary aspergillosis and invasive disease in hiv infected patients
3. 液体呼吸 liquid ventilation
4. 気管の放射線学 radiology of the trachea
5. 嫌気菌：ヒトの正常細菌叢における歴史および役割 anaerobic bacteria history and role in normal human flora

English Journal

Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-α1.

Fanelli V1, Morita Y, Cappello P, Ghazarian M, Sugumar B, Delsedime L, Batt J, Ranieri VM, Zhang H, Slutsky AS.
Anesthesiology.Anesthesiology.2016 Jan;124(1):132-40. doi: 10.1097/ALN.0000000000000907.
BACKGROUND: Neuromuscular blocking agents (NMBAs) bind the nicotinic acetylcholine receptor α1 (nAChRα1) that also contributes to inflammatory signaling. Thus, the author hypothesized that the use of NMBA mitigates lung injury by improving ventilator synchrony and decreasing inflammatory responses
PMID 26540149

Exposure to cigarette smoke and Chlamydia pneumoniae infection in mice: Effect on infectious burden, systemic dissemination and cytokine responses: A pilot study.

Kumar S1, Smith-Norowitz TA1, Kohlhoff S1, Apfalter P1, Roblin P1, Kutlin A1, Harkema J2, Ng SP3, Doherty-Lyons S4, Zelikoff JT4, Hammerschlag MR1.
Journal of immunotoxicology.J Immunotoxicol.2016 Jan;13(1):77-83. doi: 10.3109/1547691X.2015.1006346. Epub 2015 Feb 2.
Cigarette smoke exposure has been considered a risk factor for infection with Chlamydia pneumoniae. C. pneumoniae infection is associated with respiratory tract infection and chronic respiratory disease, which is a serious public health concern. To determine whether prior exposure to cigarette smoke
PMID 25640695

A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the Lungs.

Lin S1, Racz J1, Tai MF1, Brooks KM1, Rzeczycki P2, Heath LJ1, Newstead MW3, Standiford TJ3, Rosania GR2, Stringer KA4.
Pharmaceutical research.Pharm Res.2016 Jan;33(1):72-82. doi: 10.1007/s11095-015-1763-6. Epub 2015 Aug 1.
PURPOSE: To gain knowledge of lung clearance mechanisms of inhaled tissue plasminogen activator (tPA).METHODS: Using an in vivo mouse model and ex vivo murine whole organ cell suspensions, we examined the capability of the lungs to utilize LRP1 receptor-mediated endocytosis (RME) for the uptake of e
PMID 26231141